Elan launches manufacturing services business
The Ireland-based drug discovery company has added a range of manufacturing services
Ireland’s Elan Drug Technologies, a business unit of Elan Corporation, has launched a Manufacturing Services business.
The range of pharmaceutical services that the drug delivery company now provides includes drug product optimisation, scale-up and commercial scale manufacturing of solid oral dosage forms.
‘For over 40 years, Elan Drug Technologies has been a leading provider of drug delivery technologies and dosage form development for the pharmaceutical market,’ said Shane Cooke, executive vice president and head of Elan Drug Technologies. ‘We look forward to expanding our services in commercial scale-up and manufacturing, where we can offer a broad range of manufacturing solutions for our clients from our facilities in Europe and the US.’
Elan provides pharmaceutical clients with process design and development expertise, process improvements as well as improved production methods in scale-up and commercial manufacturing.
To support the launch of its Manufacturing Services business, Philip Pratten joins the Elan team as vice president, Manufacturing Services Operations. He has previously worked with Catalent Pharma Solutions, Cardinal Health, GlaxoWellcome and the Wellcome Foundation.
